BON Stock Analysis: Buy, Sell, or Hold?

BON - Bon Natural Life Limited Class A Ordinary Shares

Medicinal Chemicals & Botanical Products
$1.30
-0.06 (-4.42%) β–Ό
5d: -8.46%
30d: -23.54%
90d: -19.26%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 23, 2026 22d

Get Alerted When BON Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: BON shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: BON is currently trading at $1.30, which is considered oversold relative to its 30-day fair value range of $1.40 to $1.60.

Technical Outlook: Technically, BON is in a strong downtrend. The price is currently testing key support at $1.33. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.4% recently.

Market Sentiment: BON has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $77.50 (+5862.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $1.40 - $1.60
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 52.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.4%)
  • BULLISH: Trading 5862.0% below Wall St target ($77.50)
  • CAUTION: 5-day price weakness (-8.5%) - monitor closely

Fair Price Analysis

30-Day Fair Range $1.40 - $1.60
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $1.33
Resistance Level $1.56
Current Trend Strong Downtrend
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 2.35
Wall Street Target $77.50 (+5862.0%)
Revenue Growth (YoY) -21.9%
Earnings Growth (YoY) -41.0%
Profit Margin -10.7%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 31, 2026 3:57 AM ET
Data refreshes hourly during market hours. Next update: 4:57 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BON.

Create Free Account

Already have an account? Log In

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LIN
Linde plc Ordinary Shares
BUY
28 analysts
$516 58 HOLD
SHW
Sherwin-Williams Co
BUY
28 analysts
$388 64 BUY
IFF
International Flavors & …
STRONG BUY
22 analysts
$91 65 BUY
APD
Air Products and Chemica…
BUY
24 analysts
$308 63 BUY
DD
Dupont De Nemours Inc
STRONG BUY
20 analysts
$53 57 HOLD

More Analysis for BON

BON Technical Chart BON Price Prediction BON Earnings Date BON Investment Advisor BON Fair Price Analyzer BON Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals